Evidence review · IV ozone therapy · Lakewood Ranch, FL
Ozone Therapy: What the Evidence Shows
A plain reading of the regulatory record and the published research on medical ozone — where there is genuine trial-level signal, where there is not, and why the FDA’s position is what it is. This page makes no claim that ozone treats any disease.
Treatments provided by Ultimate IV and Wellness · 7262 55th Avenue E, Bradenton, FL 34203
- FDA position quoted, not paraphrased
- 2025–2026 literature cited
- Zero disease claims
- Independent of what we sell
- Lakewood Ranch, FL
Regulatory position
FDA: no known useful application
Disease claims made on this page
Zero
Where the evidence is strongest
Zoster-associated pain
The Short Answer on the Evidence
The FDA’s published position, unchanged since it was written, is that ozone is “a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy” (21 CFR 801.415). That is the anchor for everything on this page. The published research is real, but most of it is small — case series, pilot trials, narrow reviews — and heterogeneous in how it is designed and reported. The one area with genuine trial-level signal is pain, specifically zoster-associated pain, not disease treatment generally.
This page reviews that research honestly, names where it is genuinely encouraging, and states plainly where it is not. It does not claim that ozone treats, cures, prevents or manages any named disease or condition — not HIV, not multiple sclerosis, not Lyme disease, not stroke, not diabetes, not macular degeneration, and not anything else. Some marketing in this category makes claims like that. We do not.
This is an evidence review, not a service description. For what MAH actually is, how a session works, screening and physician oversight, see IV Ozone Therapy (MAH).
What Regulators and Major Medical Institutions Say About Ozone
Quoted directly, not paraphrased into something softer.
01
US FDA — 21 CFR 801.415
Ozone is “a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy.” This is a formal regulatory position, not a passing comment, and it has not changed.
02
US EPA
States plainly that ozone is unauthorised for use as a medical treatment and is a toxic lung irritant, with no accepted scientific evidence that it is safe or effective for treating disease.
03
Cleveland Clinic
Lists respiratory toxicity and the risk of harm from unregulated medical use among the principal disadvantages of ozone therapy, alongside its description of the procedure itself.
04
New York State Department of Health
Warns that ozone therapy is not an approved treatment for any disease and cautions patients against clinics that claim otherwise.
What Proponents Propose — and Why Proposed Is Not Proven
Two mechanisms come up constantly in ozone literature. Both are hypotheses under investigation, not settled physiology, and treating them as established fact is exactly the kind of overreach this page avoids.
Oxidative preconditioning
The proposal that a controlled, brief oxidative stimulus might train the body’s own antioxidant defenses to respond more effectively later. This is a proposed model, studied mostly in small or laboratory settings, not a demonstrated clinical effect.
Modulation of antioxidant enzyme systems
Some studies report changes in enzymes such as superoxide dismutase and glutathione peroxidase after exposure. A measurable biochemical change is not the same as a demonstrated health benefit, and the studies reporting it are generally small and short.
Why this distinction matters
A proposed mechanism explains why researchers keep studying something. It does not, on its own, establish that the something works. The gap between a plausible mechanism and a proven clinical benefit is exactly where most of the disease claims in this industry are made.
Ozone Therapy Evidence, Condition by Condition
Graded by what kind of study actually exists, because that is the honest way to read any of this.
Area studied
What the literature shows
Zoster-associated pain
The strongest single area on this page. A 2026 meta-analysis with trial sequential analysis of randomized trials, searched to September 2025, found genuine signal here.
Dental and select musculoskeletal applications
A comparatively larger, more controlled literature than most other areas. Still not the same as an established, broadly indicated treatment, and it does not extend to systemic disease.
Mechanically ventilated COVID-19 patients
Pilot randomized trials exist. The evidence base is described in the literature itself as of low quality and inconsistency.
Acute ischaemic stroke
Explored in early studies. Findings are preliminary, not an established use.
Cancer-related pain, fatigue, anxiety, depression
Covered by a scoping review — a map of what has been studied, not a verdict that it works.
Chronically refractory wounds and ulcers
A systematic review exists. Sample sizes are small and study quality is mixed.
Named systemic diseases marketed elsewhere — HIV, MS, Lyme disease, stroke, diabetes, macular degeneration and similar
No controlled trial evidence supports treating these conditions with ozone. We do not offer or claim ozone for any of them.
This table describes published research, not services we provide or outcomes we promise. We provide MAH under informed consent because patients ask for it, not because the evidence supports treating any disease.
“Ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy.”
US FDA, 21 CFR 801.415
Two Categories of Claim About Ozone Therapy
The difference between them is the entire subject of this page.
Backed by controlled trial data
Zoster-associated pain, evaluated in a 2026 meta-analysis with trial sequential analysis of randomized trials. A comparatively larger literature in dental and some musculoskeletal applications. Narrow, pain-focused, and still not the same as an established broad indication.
Not backed by controlled trial data
Claims that ozone treats named systemic diseases — conditions like HIV, multiple sclerosis, Lyme disease, stroke, diabetes and macular degeneration appear in ozone marketing across this industry, including on pages published by our own parent brand. No controlled trial evidence supports any of it, and we do not repeat those claims on this site.
Why Study Design Decides What a Result Means
Two studies can look alike at first glance and mean very different things, and the difference is almost always the design, not the disease.
A case series describes what happened to a group of patients who all received the same treatment, with no comparison group. It can flag a signal worth investigating further, but it cannot show that the treatment caused the outcome — there is nothing to compare it against.
A randomized controlled trial assigns patients to receive the treatment or not, at random, specifically so the two groups differ only by the treatment. That is what lets a result be attributed to the treatment rather than to who happened to volunteer for it.
A meta-analysis combines multiple trials for a clearer, more stable estimate than any single study alone. A trial sequential analysis, layered onto a meta-analysis, checks whether enough evidence has actually accumulated to draw a firm conclusion — a meaningfully higher bar than simply pooling whatever trials exist.
Most of the ozone literature outside zoster-associated pain sits at the case-series end of that spectrum. That is not a reason to dismiss it outright — it is a reason to describe it accurately, which is what this page tries to do.
How to Evaluate Any Claim Made About Ozone Therapy
Three questions worth asking before taking any clinic’s word for it, including ours.
01
Ask what kind of study backs it
A case series is not the same as a randomized trial, and a randomized trial is not the same as a meta-analysis. Ask, or look for the word.
02
Ask which regulator supports it
The FDA, EPA and major medical institutions have published positions on ozone. If a claim contradicts all of them, that is worth noticing rather than dismissing.
03
Ask whether the claim is about a disease or supportive use
There is a real difference between a specific, studied use under investigation and a claim that something “treats HIV.” The second kind of claim should raise questions about everything else on that page.
Where the Literature Is Comparatively Larger — and Where It Still Does Not Reach
Dental applications and some musculoskeletal uses of ozone carry a somewhat larger and more controlled literature than most of the rest of this field. That is worth stating plainly, because it is a genuine difference rather than a uniform picture of weak evidence everywhere.
It does not extend the reasoning to systemic disease. A larger literature in a narrow, local application — a tooth, a joint, a small area of tissue — says nothing about whether ozone treats an autoimmune condition, a chronic infection, or a neurological disease. Those are different claims, requiring their own evidence, and that evidence largely does not exist.
Much of this is also, in practice, a literature generated and applied outside the US regulatory framework. A good share of published ozone research originates from and is practiced in countries where it holds a different standing in conventional medical settings than it does here. That context matters when weighing how directly any given result applies to a clinic in the United States.
Where the Evidence Is Weak or Absent, in the Literature's Own Words
Quoted from the studies themselves, not summarized into something more flattering.
Areas explored in early or pilot research
Mechanically ventilated COVID-19 patients, acute ischaemic stroke, cancer-related symptoms, and chronically refractory wounds all have some published research. None of it rises to the level of an established, broadly supported treatment.
What the studies say about themselves
“The predominance of case-series designs and limited sample sizes fundamentally constrains the generalizability of findings.” Evidence in COVID-19 and viral infection is described as “of low quality and inconsistency,” with “limited sample sizes, lack of randomization, and significant heterogeneity in treatment protocols.”
Why This Page Does Not Repeat Claims Made Elsewhere About Ozone
This needs saying directly rather than left implied. Ozone therapy is marketed, across this industry and including on pages published by our own parent brand, as a treatment for a long list of named diseases — HIV, multiple sclerosis, Lyme disease, stroke, diabetes, hepatitis and macular degeneration among them. This page does not repeat any of those claims, and none of them appear anywhere else on this site.
The reason is straightforward. No controlled trial evidence supports treating those conditions with ozone. The FDA’s position — that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy — exists precisely because claims like these have outrun what the research actually shows. Repeating them here would mean asserting something we cannot support, to a reader trying to make a real decision about their health.
What we do claim: that MAH ozone therapy is a real procedure with a defined process, that the published literature shows genuine trial-level signal in zoster-associated pain specifically, and that dental and some musculoskeletal applications carry a somewhat larger literature than most other areas. What we do not claim: that it treats, cures, prevents or manages any named disease. That distinction is the entire point of this page.
For what we actually offer — the procedure, screening, physician oversight and what a session involves — see IV Ozone Therapy (MAH).
Why an Evidence Page Needed Physician Oversight Too
This page went through the same standard as any clinical claim on this site: a claim is either supported by real evidence and stated as such, or it is not made at all. That standard applies as much to what we choose not to say as to what we do say.
Our medical director reviews the clinical positioning behind every service we offer, including where the evidence for that service is genuinely limited. Ozone is the clearest example of that discipline in practice.
Medical director: Dr Stephen Jones — board-certified general surgeon since 2016, Northeast Ohio Medical University. Founder and lead nurse: Erica Barshay, RN BSN.
Where Ozone Therapy Sits on Our Menu
This page reviews the evidence; it does not set expectations about outcomes or cost. Current pricing for MAH ozone therapy, alongside the rest of our menu, is published in one place.
If you are weighing ozone against another option, a conversation with a nurse is a more useful starting point than any web page, including this one.
Ozone Therapy Evidence Questions Patients Ask
It depends entirely on what “work” means. The FDA’s position is that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy, and most of the published research is small and heterogeneous. The one area with genuine trial-level signal is zoster-associated pain. It is not established for disease treatment generally, and we do not claim that it is.
Some. A 2026 meta-analysis with trial sequential analysis of randomized trials found genuine signal for zoster-associated pain. Dental and some musculoskeletal applications carry a somewhat larger, more controlled literature than most other areas. Outside of that, most published work is case series and pilot studies — real, but not the kind of evidence that supports a broad claim.
No. The FDA’s formal position, published at 21 CFR 801.415, is that ozone is a toxic gas with no known useful medical application in specific, adjunctive, or preventive therapy. That position has not changed.
Published research includes zoster-associated pain (the strongest area), mechanically ventilated COVID-19 patients, acute ischaemic stroke, cancer-related symptoms, and chronically refractory wounds. None of that research supports treating those conditions with ozone as an established therapy — most of it is preliminary.
That is a fair question to ask any clinic, including this one. Marketing in this category often lists named diseases — HIV, multiple sclerosis, Lyme disease, diabetes, macular degeneration and others — with no controlled trial evidence behind the claim. Some of that marketing appears on pages published by our own parent brand. We do not repeat those claims on this site.
A case series describes what happened to a group of patients who all received the same treatment, without a comparison group. It can flag something worth studying further, but it cannot show the treatment caused the result. Most of the ozone literature outside zoster-associated pain sits at this level.
That is a decision for you and a clinician who knows your history, not something this page can answer. What we can do is be honest about what the evidence supports and what it does not, so you are deciding with accurate information rather than a marketing claim.
Book
Ask Us About the Evidence Before You Book
If you want to talk through what the research does and does not support, or how MAH ozone therapy actually works, a nurse will talk you through it plainly — including the parts that are not established.
Prefer to talk?
Call and a nurse
answers the phone.
Not a call center, not a booking bot.
What happens next
- We read it the same day
- A nurse calls you back, not a booking bot
- We will tell you plainly what the evidence does and does not support
Mon–Fri 8am–6pm · Sat 8am–2pm · Sun closed
Treatments provided by Ultimate IV and Wellness · 7262 55th Avenue E, Bradenton, FL 34203